Intelligent Nanocellulose-Based Medical Implant Systems
Legal Citation
Summary of the Inventive Concept
The present inventive concept integrates nanocellulose-based medical implants with cutting-edge technologies like AI, IoT, blockchain, and advanced materials to create novel, high-performance systems for bile duct repair and other medical applications.
Background and Problem Solved
The original patent for a medical implant based on nanocellulose addressed the critical issue of bile duct reconstruction in hepato-biliary surgery. However, the original invention had limitations in terms of implant customization, placement optimization, and post-operative monitoring. The new inventive concept overcomes these limitations by synergistically combining the nanocellulose-based implant with AI-powered surgical planning, IoT-enabled sensors, blockchain-based tracking, and advanced materials.
Detailed Description of the Inventive Concept
The inventive concept comprises a nanocellulose-based medical implant produced using a microbial cellulose tube, which is integrated with one or more of the following technologies: an AI-powered surgical planning module for optimizing implant placement; machine learning algorithms for generating customized implant designs based on patient-specific data; an IoT-enabled sensor for monitoring implant performance and detecting potential complications; a blockchain-based decentralized ledger for recording and verifying implant production, distribution, and usage; and a composite material incorporating the nanocellulose-based matrix with reinforcing materials like graphene, carbon nanotubes, or metal nanoparticles.
Novelty and Inventive Step
The new claims introduce a novel combination of the nanocellulose-based implant with distinct technologies, resulting in a synergistic system that provides improved performance, customization, and monitoring capabilities. The inventive step lies in the integration of these technologies to create a more powerful and effective system for bile duct repair and other medical applications.
Alternative Embodiments and Variations
Alternative embodiments of the inventive concept could include the use of different AI algorithms for surgical planning, varying types of IoT sensors for implant monitoring, or alternative blockchain platforms for tracking and verification. Additionally, the nanocellulose-based matrix could be combined with other reinforcing materials or used in conjunction with other medical implant technologies.
Potential Commercial Applications and Market
The intelligent nanocellulose-based medical implant systems have significant commercial potential in the medical device industry, particularly in the areas of hepato-biliary surgery, tissue engineering, and personalized medicine. The target market includes hospitals, research institutions, and medical device manufacturers seeking innovative solutions for complex medical procedures.
CPC Classifications
| Section | Class | Group |
|---|---|---|
| A | A61 | A61F2/04 |
| A | A61 | A61L31/005 |
| A | A61 | A61L31/10 |
| A | A61 | A61L31/146 |
| A | A61 | A61F2002/041 |
| A | A61 | A61L2400/12 |
| A | A61 | A61L2420/08 |
| C | C08 | C08L1/02 |
Original Patent Information
| Patent Number | US 11,857,405 |
|---|---|
| Title | Medical implant based on nanocellulose |
| Assignee(s) | UNIVERSITÄTSKLINIKUM JENA |